NRGene and Top Seeds International have signed a collaboration agreement to develop and commercialize new and improved cherry tomato varieties. Based on the agreement, NRGene will lead the research by applying its AI technology to accelerate and improve the accuracy of the breeding process, while Top Seeds will take responsibility for product development, marketing, and commercialization.
Alon Lerner, the Innovation and Collaboration lead in Top Seeds: “Developing new varieties takes years and requires large investments. We are at the technological forefront to discover important traits, optimize breeding processes, and shorten the time to market of new varieties. This collaboration allows us to apply NRGene’s solutions to our genetics, enabling both our companies to improve our position in the seed market further.”
NRGene estimates the investment in this project at US$400,000, while its market potential in the targeted regions was estimated at US$25 million in 2020. Following successful completion of the project, NRGene will be entitled to royalties of 35-70% from the sales (net of production and distribution costs) of the improved seeds and varieties, based on their genetic content. The first revenues from this project are expected in 2025.
“This partnership fulfills NRGene’s strategic decision to deepen our involvement in variety development and our presence in the seed industry value chain,” said Dr. Gil Ronen, NRGene’s CEO and founder.
For more information:
NRGene
Tel +972.72.2203750
Fax +972.8.6489897
[email protected]
www.nrgene.com
Top Seeds International
Moshav Sharona, Lower Galilee 1523200, Israel
Tel: +972-4-953-0148
Fax: +972-4-662-0673
[email protected]
topseedsltd.com